Return to Publications
April 2018
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.
Joseph R. Bertino, MD

Lifetime Dedication

Rutgers Cancer Institute of New Jersey medical oncologist Joseph R. Bertino, MD, has been named the recipient of the American Association for Cancer Research 2018 Lifetime Achievement Award. The award recognizes individuals who have made significant fundamental contributions to cancer research, either through a single scientific discovery or a collective body of work. For more than 50 years, Dr. Bertino, who is also a university professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School, has taken care of thousands of patients with lymphoma and other blood cancers, while also trying to unlock the mysteries of these diseases through research.

Steven K. Libutti, MD, FACS

Affecting Change in Healthcare

Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ to its Power 100 list. NJBIZ editors looked at legislators, educators and business leaders around the state to find those who are affecting change and fostering growth in their respective fields. Also on the list are RWJBarnabas Health executives Barry H. Ostrowsky, president and chief executive officer of RWJBarnabas Health; Amy Mansue, president of the Southern Region for RWJBarnabas Health; and Michellene Davis, Esq., executive vice president and chief corporate affairs officer, RWJBarnabas Health, along with Rutgers University President Robert Barchi, MD, PhD.


A Boost for Nursing Education at Rutgers Cancer Institute

Rutgers Cancer Institute of New Jersey has earned the prestigious accreditation as a provider of continuing nursing education by the American Nurses Credentialing Center. The accreditation means thatnurses served by our programs gain access to the highest caliber of education to meet certification or licensure requirements, while patients are assured they're receiving care provided by nurses who have demonstrated current, evidence-based knowledge of the spectrum of cancer care.

pancreatic cancer

Exploring the Impact of a Diabetes Drug on Pancreatic Cancer

Research by Rutgers Cancer Institute of New Jersey finds that targeting a certain signaling pathway with a diabetes drug may be a novel prevention and treatment strategy for pancreatic cancer progression. Rutgers Cancer Institute researcher Xiang-Lin Tan, MD, PhD, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School and an assistant professor of epidemiology at Rutgers School of Public Health, is the senior investigator of the work that will be presented at the American Association for Cancer Research Annual Meeting later this month.


Peritoneal Mesothelioma: What Is It?

With spring home improvement projects come warnings about safe removal of construction and home materials made of asbestos in older homes, as exposure to this fibrous mineral is a known risk factor to the development of lung cancer and mesothelioma. Many people know about lung cancer, but not mesothelioma. Rutgers Cancer Institute of New Jersey Chief Surgical Officer H. Richard Alexander, Jr., MD, FACS, professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more about this rare cancer.